IL33 and diabetes mellitus: For instance, study (Liu 2023) examined IL-33/ST2L signaling pathway in DKD used flow cytometry to assess apoptosis in glomerular endothelial cells, showing that in diabetes mice, IL-33 therapy decreased endoplasmic reticulum stress and cellular death.